Xiang Ji

Senior Director of Medicinal Chemistry

Risen (Shanghai) Pharma

Short Biography

Ph.D. from Fudan University with over a decade of professional experience in innovative drug discovery and development. Specialized in degenerative diseases and oncology therapeutics, having spearheaded the development of multiple drug candidates advancing through clinical stages. As a core inventor listed on key patents, successfully propelled several novel drug research achievements into clinical translation phases.

Presentation Topic: Discovery of a Potent and Orally Bioavailable Pan-KRAS PROTAC
• Targeting Pan-KRAS Degradation via PROTACs
• Discovery of a Potent and Orally Bioavailable Pan-KRAS PROTAC – RP04340
• Summary
• Acknowledgements